Table 1 Baseline characteristics of the patients qualified for hysterectomy, ulipristal acetate treatment or uterine artery embolization
Supracervical hysterectomy | UPA | UAE | P | |
|---|---|---|---|---|
Number of patients | 26 | 27 | 30 | N/A |
Age | 38 (36–43) | 37 (34–43) | 35 (33–40) | > 0.05 |
Parity | 2 (1–2) | 2 (1–2) | 1 (1–2) | > 0.05 |
Dominant fibroid Volume (cm3) | 103.3 (87.6–127.6) | 104.6 (85.2–132.1) | 107.75 (87.4–131.1) | > 0.05 |
Hemoglobin (g/dl) | 10.5 (9.0–11.9) | 10.2 (8.9–11.1) | 10.3 (9.1–11.4) | > 0.05 |
BMI (kg/m2) | 27.5 (23.6–31.3) | 28.1 (24.1–32.9) | 26.9 (22.5–30.6) | > 0.05 |